| 2017 September-December |
| Date | Presenter |
Journal |
| 10 October, 2018 | Takayuki Chikata (Assistant Professor) |
Cheng L, et al. TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs. J Clin Invest. 2018 Oct 1;128(10):4387-4396. doi: 10.1172/JCI99005. Epub 2018 Aug 27. |
| 3 October, 2018 | Tomohiro Akahoshi (Postdoctoral Fellow) |
Mendoza P, et al. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 Sep;561(7724):479-484. doi: 10.1038/s41586-018-0531-2. Epub 2018 Sep 26. |
| 19 September, 2018 | Yu Zhang (D2) |
Clayton KL, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018 May;19(5):475-486. doi: 10.1038/s41590-018-0085-3. Epub 2018 Apr 18. |
| 12 September, 2018 | Hayato Murakoshi (Lecturer) |
Salantes DB, et al. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J Clin Invest. 2018 Jul 2;128(7):3102-3115. doi: 10.1172/JCI120194. Epub 2018 Jun 18. |